158 related articles for article (PubMed ID: 29889803)
1. Successful Treatment of Pediatric Epstein-Barr Virus-positive Aggressive Natural Killer-Cell Leukemia.
Kim BK; Hong KT; Kang HJ; An HY; Choi JY; Hong CR; Park KD; Lee DS; Shin HY
J Pediatr Hematol Oncol; 2019 Jul; 41(5):e336-e337. PubMed ID: 29889803
[TBL] [Abstract][Full Text] [Related]
2. Achievement of disease control with donor-derived EB virus-specific cytotoxic T cells after allogeneic peripheral blood stem cell transplantation for aggressive NK-cell leukemia.
Haji S; Shiratsuchi M; Matsushima T; Takamatsu A; Tsuda M; Tsukamoto Y; Tanaka E; Ohno H; Fujioka E; Ishikawa Y; Imadome KI; Ogawa Y
Int J Hematol; 2017 Apr; 105(4):540-544. PubMed ID: 27830541
[TBL] [Abstract][Full Text] [Related]
3. Favorable outcome in a child with EBV-negative aggressive NK cell leukemia.
Park JA; Jun KR; Nam SH; Ghim TT
Int J Hematol; 2013 May; 97(5):673-6. PubMed ID: 23550023
[TBL] [Abstract][Full Text] [Related]
4. Successful allogeneic hematopoietic stem cell transplantation for aggressive NK cell leukemia.
Ichikawa S; Fukuhara N; Yamamoto J; Suzuki M; Nakajima S; Okitsu Y; Kohata K; Onishi Y; Ishizawa K; Kameoka J; Harigae H
Intern Med; 2010; 49(17):1907-10. PubMed ID: 20823655
[TBL] [Abstract][Full Text] [Related]
5. Identification of a novel CCDC22 mutation in a patient with severe Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis and aggressive natural killer cell leukemia.
Yamashita Y; Nishikawa A; Iwahashi Y; Fujimoto M; Sasaki I; Mishima H; Kinoshita A; Hemmi H; Kanazawa N; Ohshima K; Imadome KI; Murata SI; Yoshiura KI; Kaisho T; Sonoki T; Tamura S
Int J Hematol; 2019 Jun; 109(6):744-750. PubMed ID: 30706328
[TBL] [Abstract][Full Text] [Related]
6. Aggressive natural killer cell leukemia: therapeutic potential of L-asparaginase and allogeneic hematopoietic stem cell transplantation.
Ishida F; Ko YH; Kim WS; Suzumiya J; Isobe Y; Oshimi K; Nakamura S; Suzuki R
Cancer Sci; 2012 Jun; 103(6):1079-83. PubMed ID: 22360679
[TBL] [Abstract][Full Text] [Related]
7. Allogeneic hematopoietic stem cell transplantation for Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disease in Japan.
Sato E; Ohga S; Kuroda H; Yoshiba F; Nishimura M; Nagasawa M; Inoue M; Kawa K
Am J Hematol; 2008 Sep; 83(9):721-7. PubMed ID: 18626884
[TBL] [Abstract][Full Text] [Related]
8. L-asparaginase-based regimens followed by allogeneic hematopoietic stem cell transplantation improve outcomes in aggressive natural killer cell leukemia.
Jung KS; Cho SH; Kim SJ; Ko YH; Kang ES; Kim WS
J Hematol Oncol; 2016 Apr; 9():41. PubMed ID: 27091029
[TBL] [Abstract][Full Text] [Related]
9. Aggressive natural killer cell leukemia: diagnosis, treatment recommendations, and emerging therapies.
Zhang Y; Lee D; Gesiotto Q; Sokol L
Expert Rev Hematol; 2021 Aug; 14(8):731-740. PubMed ID: 34263714
[TBL] [Abstract][Full Text] [Related]
10. Allogeneic Hematopoietic Cell Transplantation for Aggressive NK Cell Leukemia. A Center for International Blood and Marrow Transplant Research Analysis.
Hamadani M; Kanate AS; DiGilio A; Ahn KW; Smith SM; Lee JW; Ayala E; Chao N; Hari P; Bolaños-Meade J; Gress R; Smedegaard Anderson N; Chen YB; Farooq U; Schiller G; Yared J; Sureda A; Fenske TS; Olteanu H
Biol Blood Marrow Transplant; 2017 May; 23(5):853-856. PubMed ID: 28161608
[TBL] [Abstract][Full Text] [Related]
11. Long term survival in aggressive NK cell leukemia.
Patel AP; Ghatak SB; Patel JA
Indian Pediatr; 2010 Sep; 47(9):807-8. PubMed ID: 21048272
[TBL] [Abstract][Full Text] [Related]
12. Aggressive natural killer cell leukemia: is Epstein-Barr virus negativity an indicator of a favorable prognosis?
Ko YH; Park S; Kim K; Kim SJ; Kim WS
Acta Haematol; 2008; 120(4):199-206. PubMed ID: 19153474
[TBL] [Abstract][Full Text] [Related]
13. Allogeneic Stem Cell Transplantation for Patients with Natural Killer/T Cell Lymphoid Malignancy: A Multicenter Analysis Comparing Upfront and Salvage Transplantation.
Jeong SH; Song HN; Park JS; Yang DH; Koh Y; Yoon SS; Lee HW; Eom HS; Won JH; Kim WS; Kim SJ
Biol Blood Marrow Transplant; 2018 Dec; 24(12):2471-2478. PubMed ID: 30064012
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological analysis of the age-related differences in patients with Epstein-Barr virus (EBV)-associated extranasal natural killer (NK)/T-cell lymphoma with reference to the relationship with aggressive NK cell leukaemia and chronic active EBV infection-associated lymphoproliferative disorders.
Takahashi E; Ohshima K; Kimura H; Hara K; Suzuki R; Kawa K; Eimoto T; Nakamura S;
Histopathology; 2011 Oct; 59(4):660-71. PubMed ID: 22014047
[TBL] [Abstract][Full Text] [Related]
15. Successful treatment of Epstein-Barr virus-associated natural killer cell large granular lymphocytic leukaemia using allogeneic peripheral blood stem cell transplantation.
Takami A; Nakao S; Yachie A; Kasahara Y; Okumura H; Miura Y; Sugimori N; Zeng W; Wang H; Kotani T; Shiobara S; Matsuda T
Bone Marrow Transplant; 1998 Jun; 21(12):1279-82. PubMed ID: 9674865
[TBL] [Abstract][Full Text] [Related]
16. Adult aggressive natural killer cell leukemia.
Zhang H; Meng Q; Yin W; Xu L; Lie L
Am J Med Sci; 2013 Jul; 346(1):56-63. PubMed ID: 23241562
[TBL] [Abstract][Full Text] [Related]
17. Promising approach for aggressive NK cell leukaemia with allogeneic haematopoietic cell transplantation.
Ito T; Makishima H; Nakazawa H; Kobayashi H; Shimodaira S; Nakazawa Y; Kitano K; Matsuda K; Hidaka E; Ishida F
Eur J Haematol; 2008 Aug; 81(2):107-11. PubMed ID: 18462253
[TBL] [Abstract][Full Text] [Related]
18. EBV-negative Aggressive NK-cell Leukemia/Lymphoma: Clinical, Pathologic, and Genetic Features.
Nicolae A; Ganapathi KA; Pham TH; Xi L; Torres-Cabala CA; Nanaji NM; Zha HD; Fan Z; Irwin S; Pittaluga S; Raffeld M; Jaffe ES
Am J Surg Pathol; 2017 Jan; 41(1):67-74. PubMed ID: 27631517
[TBL] [Abstract][Full Text] [Related]
19. EBV-associated aggressive natural killer cell leukemia.
Rashidi A; Fisher SI
Blood; 2016 May; 127(20):2502. PubMed ID: 28092886
[No Abstract] [Full Text] [Related]
20. The hepatic niche leads to aggressive natural killer cell leukemia proliferation through the transferrin-transferrin receptor 1 axis.
Kameda K; Yanagiya R; Miyatake Y; Carreras J; Higuchi H; Murayama H; Ishida T; Ito A; Iida S; Fukuhara N; Harigae H; Fujioka Y; Takahashi N; Wada H; Ishida F; Nakazawa H; Ishihara R; Murakami Y; Tagawa H; Matsuura T; Nakagawa S; Iwabuchi S; Hashimoto S; Imadome KI; Nakamura N; Ishizawa K; Kanda Y; Ando K; Kotani A
Blood; 2023 Jul; 142(4):352-364. PubMed ID: 37146246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]